Polsinelli Podcasts - Confusion to Clarity on the Future of the 340B Program
On June 24, HRSA announced that it had issued new grant award terms to its HRSA-funded health centers to provide insulin and injectable epinephrine at or below the 340B price paid by the health center for the drugs. HRSA...more
The initial phase of Provider Relief Funds (“Funds”) was distributed in April 2020, and since then, many providers have been playing catch up. The Health Resources & Services Administration (HRSA) recently addressed two...more